Clinical Trials Browser

Phase NA × Not yet recruiting × Lymphoma, T-Cell, Peripheral × Clear all

NCT06671717 2024-11-06

Pralatrexate Combined With Chidamide Bridging Allogeneic HSCT for Refractory/Relapsed Peripheral T-cell Lymphoma

Phase NA Not yet recruiting

Lymphoma, T-Cell, Peripheral